All In MedTech

Device Trial Radar · NCT03900260

Clinical Evaluation of the Lenstec Softec HP1 Intraocular Lens

Last checked: Nov 19, 2026Latest source record: Feb 15, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

87

Actual

Start

Apr 25, 2019

Primary completion

Jul 22, 2021

Study completion Jul 22, 2021

Sponsor

Lead sponsor
Lenstec IncorporatedNot on our public-company list
Sponsor type
Industry
First posted
Apr 3, 2019

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Other
FDA-regulated device
No
Who can join
All sexes, from 21 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The study is designed as a post market evaluation of the Softec HP1 IOL for continuance of the CE certificate. The primary effectiveness endpoint is to evaluate the safety and performance levels produced by this IOL in patients requiring standard cataract surgery. There will be no change from standard procedure, other than 1 extra post op evaluation.

Conditions

  • Aphakia

Interventions

  • Softec HP1 Intraocular LensDevice

    The Softec HP1 IOL is a single-piece, biconvex, ultraviolet absorbing intraocular lens designed for insertion into the posterior chamber of the human eye for visual correction of Aphakia in adults over the age of 21, and as a replacement of a damaged (cataract) natural lens.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Best Corrected Distance Visual Acuity (BCDVA)Time frame: 3 months

Locations

3 sites in 1 country. Site status is shown where the registry gives one.

  • Croft Shifa health Centre

    Rochdale, United Kingdom

  • Midland Eye Institute

    Solihull, United Kingdom

  • Sunderland Eye Infirmary

    Sunderland, United Kingdom

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.